Real World Evidence of the Effectiveness of Paritaprevir/Ritonavir (r) - Ombitasvir, + Dasabuvir Without Ribavirin in Participants With Chronic Hepatitis C and Compensated Liver Cirrhosis in the Russian Federation

NCT03053180 · clinicaltrials.gov ↗
COMPLETED
Status
60
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

AbbVie